104 related articles for article (PubMed ID: 24312348)
41. Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India.
Gautam A; Chakravarty J; Singh VK; Ghosh A; Chauhan SB; Rai M; Sundar S
BMC Infect Dis; 2018 Dec; 18(1):692. PubMed ID: 30587145
[TBL] [Abstract][Full Text] [Related]
42. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
43. Risk of CIN2+ following a diagnosis of genital warts: a nationwide cohort study.
Blomberg M; Dehlendorff C; Kjaer SK
Sex Transm Infect; 2019 Dec; 95(8):614-618. PubMed ID: 31092605
[TBL] [Abstract][Full Text] [Related]
44. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
45. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
[TBL] [Abstract][Full Text] [Related]
47. HIV and development of epithelial cell abnormalities in women with prior normal cervical cytology in Nigeria.
Musa J; Mehta SD; Achenbach CJ; Evans CT; Jordan N; Magaji FA; Pam VC; Daru PH; Silas OA; Sagay AS; Anorlu R; Zheng Y; Maiga M; Adewole IF; Murphy RL; Hou L; Simon MA
Infect Agent Cancer; 2020; 15():50. PubMed ID: 32760435
[TBL] [Abstract][Full Text] [Related]
48. Giant anal warts.
Mulita F; Tavlas P; Iliopoulos E; Maroulis I
Clin Case Rep; 2020 Sep; 8(9):1856-1857. PubMed ID: 32983519
[TBL] [Abstract][Full Text] [Related]
49. A deadly cold.
Kolade VO
Proc (Bayl Univ Med Cent); 2022; 35(3):398. PubMed ID: 35518829
[TBL] [Abstract][Full Text] [Related]
50. Wart are These Lesions?
Verma SB
Indian Dermatol Online J; 2022; 13(3):427-428. PubMed ID: 36226002
[No Abstract] [Full Text] [Related]
51. Screening for Human Papillomavirus-Associated Cervical Disease in HIV-Infected Women.
Keller MJ
Top Antivir Med; 2015; 23(4):142-5. PubMed ID: 26713504
[TBL] [Abstract][Full Text] [Related]
52. Clinical implications of the cervical Papanicolaou test results in the management of anal warts in HIV-infected women.
Luu HN; Amirian ES; Beasley RP; Piller L; Chan W; Scheurer ME
PLoS One; 2013; 8(11):e81751. PubMed ID: 24312348
[TBL] [Abstract][Full Text] [Related]
53. Anal papanicolaou smear in women with abnormal cytology: a thai hospital experience.
Sananpanichkul P; Pittyanont S; Yuthavisuthi P; Thawonwong N; Techapornroong M; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2015; 16(3):1289-93. PubMed ID: 25735369
[TBL] [Abstract][Full Text] [Related]
54. Association between smoking and size of anal warts in HIV-infected women.
Luu HN; Amirian ES; Beasley RP; Piller L; Chan W; Scheurer ME
Int J STD AIDS; 2012 Nov; 23(11):792-8. PubMed ID: 23155099
[TBL] [Abstract][Full Text] [Related]
55. Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women.
Cimic A; Wilkin TJ; Heymann JJ; Alperstein S; Ellsworth G; Siddiqui MT
Cancer Cytopathol; 2019 Jun; 127(6):407-413. PubMed ID: 31145557
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
